NCT04147754

Brief Summary

Pulmonary thoracic surgery is often responsible for severe postoperative pain, which is associated with an increase in postoperative morbidity and mortality. Moreover, postoperative thoracic pain has a strong impact on patient rehabilitation and is associated with an increase in hospital stay. Various analgesic techniques allow effective management of pain in the context of thoracic surgery. Regional anesthesia, particularly, allows a powerful analgesia, and limits the use of opioids and their side effects. Among regional anesthesia techniques, thoracic epidural analgesia has become the gold standard for post-thoracotomy analgesia. However, it induces a sympathetic block that promotes in particular per and postoperative hypotension and acute urinary retentions. Thus, new regional anesthesia techniques have been developed and assessed in thoracic surgery in order to avoid side effects related to epidural analgesia, particularly paravertebral block and erector spinae block, but also intrathecal analgesia. Paravertebral block has shown analgesic efficacy after thoracic surgery, and its interest in reducing the risk of hypotension, acute urinary retention, pruritus and postoperative nausea and vomiting compared with the epidural analgesia. Erector spinae block, recently described and evaluated in this context of thoracic surgery, seems to have the same interests and to be easier to achieve than the paravertebral block, but has been little studied. Finally, intrathecal morphine is frequently used because of an easy and rapid realization, and because it allows an adequate analgesia and the reduction of the duration of stay in intensive care compared to the epidural one. However, despite its frequent use, very few studies have compared intrathecal anesthesia with the epidural and other peri-spinal blocks. These three types of analgesia, epidural analgesia, intrathecal morphine, and erector spinae block are regional anesthesia methods regularly used for pulmonary surgery in the department of the investigators. All of these techniques have shown their analgesic efficacy, but each seems to have particular respective interests, in terms of achievement, management, or perioperative rehabilitation. The objective of the investigators study is to evaluate the effectiveness of each of its techniques to treat postoperative pain and improve the rehabilitation of these patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 1, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

November 4, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

November 1, 2019

Status Verified

October 1, 2019

Enrollment Period

12 months

First QC Date

October 24, 2019

Last Update Submit

October 29, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain assessment at H+48

    Numerical pain rating scale: 0 (no pain at all) to 10 (worst imaginable pain)

    Day 2 after surgery

Secondary Outcomes (6)

  • Total consumption of morphine (per and postoperative)

    Hour 2, Day 1, Day 2 and Day 3 after surgery.

  • Length of stay in intensive care unit

    Through study completion, an average of 1 year

  • Length of hospital stay

    Through study completion, an average of 1 year

  • Impact on respiratory function

    Day 1, Day 2 and Day 3 after surgery.

  • Frequency of adverse effects related to morphine Frequency of morphine side effects

    Hour 2, Day 1, Day 2 and Day 3 after surgery.

  • +1 more secondary outcomes

Study Arms (3)

Epidural anesthesia

At physician discretion (observational study)

Procedure: Epidural anesthesia

Intrathecal morphine

At physician discretion (observational study)

Procedure: Intrathecal morphine

Erector spinae block

At physician discretion (observational study)

Procedure: Erector spinae block

Interventions

Preoperative epidural anesthesia at physician discretion

Epidural anesthesia

Preoperative intrathecal morphine at physician discretion

Intrathecal morphine

Preoperative erector spinae block at physician discretion

Erector spinae block

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing thoracic surgery for pulmonary resection in the University Hospital of Angers, in France.

You may qualify if:

  • Thoracic surgery for pulmonary resection
  • Scheduled regional anesthesia: epidural anesthesia, intrathecal morphine or erector spinae block

You may not qualify if:

  • No epidural anesthesia or no intrathecal morphine or no erector spinae block performed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Angers - DEPARTEMENT D'ANESTHESIE REANIMATION

Angers, 49100, France

Location

MeSH Terms

Interventions

Anesthesia, Epidural

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Emmanuel Rineau, MD

    University Hospital of Angers, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emmanuel Rineau, MD

CONTACT

Laurent Beydon, MD PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2019

First Posted

November 1, 2019

Study Start

November 4, 2019

Primary Completion

November 1, 2020

Study Completion

February 1, 2021

Last Updated

November 1, 2019

Record last verified: 2019-10

Locations